Table 5.

ICU mortality and each glycemic condition with/without hypoalbuminemia

Glycemic conditions	Odds	95% CI	p value
Hypo-G	3.503	1.7820–6.9351	0.0003
Inter-G	1.175	0.7324–1.9093	0.5083
Hyper-G	1.756	1.0150–3.1443	0.0439
Hypo-G + Hypo-A	5.065	2.1664–12.498	0.0002
Inter-G + Hypo-A	1.925	1.1487–3.2115	0.0131
Hyper-G + Hypo-A	0.980	0.4349–2.0552	0.9591
aInter-G + Nonhypo-A	0.349	0.1897–0.6152	0.0002
Other parameters
APACHE II score	1.116	1.0753–1.1611	< 0.0001
SOFA score	1.256	1.1559–1.3737	< 0.0001
Hypo-A	3.243	1.9774–5.3957	< 0.0001

Odds ratio of each glycemic condition, SOFA score, and/or hypoalbuminemia, respectively, were independently calculated by a single logistic regression analysis of the initial laboratory data at the time of admission due to multicollinearity. In each Hypo-A, Inter-G + Nonhypo-A, Hypo-G + Hypo-A, Inter-G + Hypo-A and Hyper-G + Hypo-A group, there were some cases which were included in more than one group

Hypo-G hypoglycemia group (blood glucose level < 80 mg/dl), Hyper-G hyperglycemia group (blood glucose level ≥ 200 mg/dl), Inter-G intermediate glycemia group (blood glucose level = 80–199 mg/dl), Hypo-A hypoalbuminemia (blood albumin < 2.8 mg/dl), Nonhypo-A non-hypoalbuminemia (blood albumin ≥ 2.8 mg/dl or more), Inter-G + Nonhypo-A patients with a glycemic level between 80 and 199 mg/dl and blood albumin 2.8 mg/dl or more, Hypo-G + Hypo-A patients with a glycemic level < 80 mg/dl and blood albumin < 2.8 mg/dl, Inter-G + Hypo-A patients with a glycemic level between 80 and 199 mg/dl and blood albumin < 2.8 mg/dl, Hyper-G + Hypo-A patients with a glycemic level ≥ 200 mg/dl and blood albumin < 2.8 mg/dl, SOFA sequential organ failure assessment

Odds ratio was higher in the “Hypo-G + Hypo-A” group than any other glycemic condition

^aInter-G + Nonhypo-A: Patients classified in this group showed a lower odds ratio for mortality